4
Changes in Ownership
Phathom Pharmaceuticals, Inc. Filed Acc 0000950170-25-031048
Options or other derivatives
- President and Chief Executive acquired 342,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Curran Terrie President and Chief Executive | 2025-02-27 | Grant or award · Stock Option (Right to Buy) | +342,500 | 342,500 | D | ||
Loading xslF345X05/ownership.xml…